Top compounds associated with response to ALDOC


Feature Type Standardized
Nominal ANOVA
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.04 0.2
mRNA AT-406 CTRPv2 pan-cancer AAC -0.06 0.2
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA ML006 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC -0.09 0.2
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.039 0.2
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.04 0.2
Download CSV